Table 1.
Control (CSE only) | Treatment (CSE with LPB) | P value | |
---|---|---|---|
N | 44 | 46 | N/A |
Sex (female, male) | 23 (52%), 21(48%) | 23 (50%), 23 (50%) | 0.829 |
Age (years) | 70 (8.00) | 70 ± 11 | 0.933 |
Height (cm) | 168 (18) | 166 ± 13 | 0.650 |
Weight (kg) | 77 (22) | 78 (24) | 0.971 |
BMI (kg/m2) | 26 (5) | 28 (5) | 0.580 |
ASA (n ASA 1 (%), n ASA 2 (%), n ASA 3 (%)) | 1 (2%), 34 (77%), 9 (20%) | 1 (2%), 40 (87%), 5 (11%) | 0.707 |
Use of preoperative anti-inflammatory drugs (meloxicam and/or dexamethasone) | 20 (45%) | 21 (46%) | 0.985 |
Length of surgery (min) | 28 (19) | 31 (15) | 0.132 |
Estimated blood loss (ml) | 150 (50) | 150 (50) | 0.498 |
Patients with 1 or more postoperative blood transfusions | 11 (25%) | 14 (30%) | 0.565 |
Postoperative drainage (ml) | 135 (300) | 180 (272) | 0.597 |
Perioperative characteristics of patients undergoing total hip arthroplasty by groups. Data presented as median (interquartile range) for continuous variables, and n (percent of group total) for categorical variables. POD-1/POD-2 = postoperative day 1/2. P values calculated using Mann–Whitney U test (continuous variables) and chi-square test (categorical variables)
CSE combined spinal–epidural anesthesia, LPB lumbar plexus block